GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pacific Edge Ltd (OTCPK:PFGTF) » Definitions » Current Ratio

Pacific Edge (Pacific Edge) Current Ratio : 6.96 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Pacific Edge Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Pacific Edge's current ratio for the quarter that ended in Mar. 2024 was 6.96.

Pacific Edge has a current ratio of 6.96. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for Pacific Edge's Current Ratio or its related term are showing as below:

PFGTF' s Current Ratio Range Over the Past 10 Years
Min: 3.98   Med: 6.67   Max: 18.43
Current: 6.96

During the past 13 years, Pacific Edge's highest Current Ratio was 18.43. The lowest was 3.98. And the median was 6.67.

PFGTF's Current Ratio is ranked better than
90.48% of 231 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.03 vs PFGTF: 6.96

Pacific Edge Current Ratio Historical Data

The historical data trend for Pacific Edge's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Edge Current Ratio Chart

Pacific Edge Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.98 6.37 18.43 11.11 6.96

Pacific Edge Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.43 14.17 11.11 10.01 6.96

Competitive Comparison of Pacific Edge's Current Ratio

For the Diagnostics & Research subindustry, Pacific Edge's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Edge's Current Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Pacific Edge's Current Ratio distribution charts can be found below:

* The bar in red indicates where Pacific Edge's Current Ratio falls into.



Pacific Edge Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Pacific Edge's Current Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Current Ratio (A: Mar. 2024 )=Total Current Assets (A: Mar. 2024 )/Total Current Liabilities (A: Mar. 2024 )
=35.204/5.059
=6.96

Pacific Edge's Current Ratio for the quarter that ended in Mar. 2024 is calculated as

Current Ratio (Q: Mar. 2024 )=Total Current Assets (Q: Mar. 2024 )/Total Current Liabilities (Q: Mar. 2024 )
=35.204/5.059
=6.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pacific Edge  (OTCPK:PFGTF) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Pacific Edge Current Ratio Related Terms

Thank you for viewing the detailed overview of Pacific Edge's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Edge (Pacific Edge) Business Description

Traded in Other Exchanges
Address
87 St David Street, P.O. Box 56, Dunedin, STL, NZL, 9016
Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.

Pacific Edge (Pacific Edge) Headlines

From GuruFocus

Full Year 2021 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Half Year 2022 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2022 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Half Year 2023 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Half Year 2024 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2023 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Trading Halt Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024